DealRay Therapeutics, a Berkeley, CA-based clinical-stage optogenetics biopharma, raised $125 million in a Series B fundraising round led by Janus Henderson Investors with participation from Adage Capital Management and Franklin Templeton.
More on VCNewsDaily →
SERIES B
04/27/2026
Tortugas Neuroscience, a Framingham, MA-based neurology and...
Alesi Surgical, a Cardiff-based surgical smoke management tech, raised £7...
Kelonia Therapeutics, Inc., a Boston-based in‑vivo CAR‑T biotech, was...
brainjo, a Regensburg, Germany-based VR-based mental health platform,...
Açaí Theory, a Bengaluru-based açaí bowl QSR, raised ₹40 million in...
Tava Health, a Salt Lake City-based mental health care platform, raised...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
